Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-01 Gordon Stephen Chief Financial Officer Sale 10b5-1 −15,000 $85.45 $1.3M 13,075
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,833 28,167
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,644 2,084
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,523 67,477
2024-01-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +2,330 $16.00 $37K 16,705
2024-01-23 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −2,330 $90.09 $210K 14,375
2024-01-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,330 5,706
2024-01-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +10,000 $13.28 $133K 24,375
2024-01-16 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −9,867 $80.40 $793K 14,508
2024-01-16 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −133 $81.06 $11K 14,375
2024-01-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −10,000 42,000
2024-01-02 Gordon Stephen Chief Financial Officer Exercise or conversion 10b5-1 +15,000 $13.28 $199K 28,075
2024-01-02 Gordon Stephen Chief Financial Officer Sale 10b5-1 −15,000 $77.07 $1.2M 13,075
2024-01-02 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −15,000 37,000
2023-12-15 Provost Miriam VP, Global Regulatory Affairs Gift −1,785 23,348
2023-12-13 Provost Miriam VP, Global Regulatory Affairs Exercise or conversion +415 $16.14 $7K 24,026
2023-12-13 Provost Miriam VP, Global Regulatory Affairs Sale −206 $75.10 $15K 23,820
2023-12-13 Provost Miriam VP, Global Regulatory Affairs Exercise or conversion +1,632 $66.10 $108K 25,452
2023-12-13 Provost Miriam VP, Global Regulatory Affairs Sale −1,509 $75.10 $113K 23,943
2023-12-13 Provost Miriam VP, Global Regulatory Affairs Exercise or conversion +3,597 $38.46 $138K 27,540

Page 22 of 38 · 744 trades